Impact of overweight on the normal physiology of human in vivo skin

Impact of overweight on the normal physiology of human in vivo skin

Jornal de Investigação Biomédica e Biofarmacêutica



Datos bibliográficos

Título traducido: Impacto do excesso de peso sobre a fisiologia normal da pele humana in vivo
Título de la revista: Jornal de Investigação Biomédica e Biofarmacêutica
Primer autor: Liliana Tavares
Otros autores: Lídia Palma;
Osvaldo Santos;
Mª Angélica Almeida;
Mª Julia Bujan;
Luis Monteiro Rodrigues
Palabras clave:
Palabras clave traducidas:
Idioma: Inglés
Portugués
Enlace del documento: http://www.alies.pt/BBR%20Editions/Vol-10-1-2013/Article5_10n1.pdf
Tipo de recurso: Documento de revista
Fuente: Jornal de Investigação Biomédica e Biofarmacêutica; Vol 10, No 1 (Año 2013).
DOI: http://dx.doi.org/10.19277/bbr.10.1.51
Entidad editora: Associação Lusófona para o Desenvolvimento da Investigação e Ensino em Ciências da Saúde
Derechos de uso: Reconocimiento - NoComercial (by-nc)
Materias: Ciencias de la Vida --> Bioquímica y Biología Molecular
Ciencias de la Salud --> Farmacia y Farmacología
Ciencias de la Salud, Ciencias de la Vida --> Fisiología

Datos estadísticos

  • Visualizaciones
  • Consultas
  • Estilo Citación
  • Compartir
  • Exportar registro
  • Favoritos
Documentos citados: [1] Wang Y, Kumanyika S, Descriptive Epidemiology of Obesity in the United States, in Hanbook of obesity prevention – a resource for health professionals, Springer science + Business Media, LLC, USA, 2007, 3: 45-71

[2] Ogden C, Yanovski S, Carroll M, Flegal K, The Epidemilogy of Obesity.Gastroenterology 2007;132:2087-2102

[3] Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009–2010. NCHS data brief, no 82. Hyattsville, MD: National Center for Health Statistics. 2012.

[4] WHO Europe: Facts and figures, in http://www.euro.who.int, 30 de Junho de 2012

[5] Do Carmo I, Santos O, Camolas J, Vieira J, Carreira M, Medina L, Reis L, Myatt J, Galvão-Teles A, Overweight and Obesity in Portugal: national prevalence in 2003-2005. Obesity Reviews (2008) 9, 11-19

[6] Sardinha L, Santos D, Silva A, Coelho-e-Silva, Raimundo A, Moreira H, Santos R, Vale S, Baptista F, Mota J, Prevalence of overweight, Obesity, and abdominal obesity in a representative sample of portuguese adults. PLoS ONE (2012) 7(10):e47883. Doi:10.1371/jornal.pone.0047883

[7] Yosipovich G, De Vore A, Dawn A . Obesity and skin: Skin physiology and skin manifestations of Obesity. J Am Acad Dermatol, 2007;6: 901-16

[8] Nino M, Franzese A, Ruggiero Perrino N, Balato N. The Effect of Obesity on Skin Disease and Epidermal Permeability Barrier Status in Children. Pediatr Dermatol. 2012 Apr 4.

[9] Guida B, Nino M, Perrino NR, Laccetti R, Trio R, Labella S, Balato N, The impact of obesity on skin disease and epidermal permeability barrier status. J Eur Acad Dermatol Venereol. 2010 Feb;24(2):191-195.

[10] Kasttorini C, Panagiotakos D, The Obesity Paradox: Methodological considerations based on epidemiological and clinical evidence – New insights. Maturitas 72 (2012) 220-224.

[11] WHO, Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. Geneva: World Health Organization, 1995

[12] República, Lei 46/2004 de 19 de Agosto.

[13] EUROPEAN DIRECTIVE 2001/20/EC on the approximation of the laws, regulations and administrative provisions of the Member State relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use, Off J Europ Communities L121/34-44, 2001.

[14] Note for Guidance on Good Clinical Practice, ICH E6GCP96, EMEA, 2002: 1-55.

[15] World Medical Association declaration of Helsinky. Ethical Principles for Medical Research Involving Human subjects, amended until 2004.

[16] WHO, Obesity: preventing and managing the global epidemic Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: World Health Organization, 2000

[17] Garrow JS, Welster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obes 1985; 9: 147–153.

[18] Rogiers V; EEMCO Group. EEMCO guidance for the assessment of transepidermal water loss in cosmetic sciences. Skin Pharmacol Appl Skin Physiol 2001;14 (2):117-28.

[19] Piérard GE, EEMCO guidance to the in vivo assessment of tensile functional properties of the skin. Part 1: relevance to the structures and ageing of the skin and subcutaneous tissues. Skin Pharmacol Appl Skin Physiol. 1999;12(6):352-62

[20] Seidenari S, Giusti F, Pellacani G, Non-Invasive Methods and Assessment of skin diseases. In: Serup J, Jemec G, Grove G, eds. Handbook Non-Invasive Methods and the skin. 2nd ed. Texas: C.H.I.P.S.; 2006:37-46

[21] Rodrigues L; EEMCO, EEMCO guidance to the in vivo assessment of tensile functional properties of the skin. Part 2: instrumentation and test modes. Skin Pharmacol Appl Skin Physiol. 2001;14(1):52-67.

[22] Darlenski R, Sassning S, Tsankov N, Fluhr JW. Non-invasive in vivo methods for investigation of the skin barrier physical properties. Eur J Pharm and Biopharm. 2009, 72:295-303

[23] Ruvolo EC, Stamatas GN, Kollias N. Skin Viscoelasticity displays site and age-dependent angular anisotropy. Skin Pharmacol Physiol, 2007, 20: 313-321